SCHEMBL6469090

SCHEMBL6469090

CS(=O)(=O)C1(S(C)(=O)=O)CCCN(CCc2nc(Nc3ccc(C(F)(F)F)cc3)c3ccc(-c4ncccc4C(F)(F)F)cc3n2)C1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4974148 0.90 TRPV1 (0.82) TRPV1
SCHEMBL4984585 0.87 TRPV1 (1.00) TRPV1
SCHEMBL4977606 0.86 TRPV1 (0.98) TRPV1
SCHEMBL4977028 0.86 TRPV1 (0.98) TRPV1
SCHEMBL4971853 0.86 TRPV1 (0.98) TRPV1
SCHEMBL4976504 0.84 TRPV1 (1.00) TRPV1
SCHEMBL6469086 0.83 TRPV1 (0.57) TRPV1
SCHEMBL4977747 0.83 TRPV1 (1.00) TRPV1
SCHEMBL4973292 0.83 TRPV1 (0.82) TRPV1
SCHEMBL4971882 0.82 TRPV1 (0.81) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581225-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2005-10-05 EP disclosed
WO-2004054582-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2004-07-01 WO disclosed